USDA Outlines Plan to Stop Bird Flu Outbreak, Lower Egg Prices
Drug Topics
FEBRUARY 26, 2025
US Secretary of Agriculture Brooke Rollins detailed her organizations plans to combat the bird flu and quell the concerns of rising grocery store costs.
Wed.Feb 26, 2025
423 
STAT+: FDA cancels vaccine advisory committee meeting
STAT
FEBRUARY 26, 2025
The Food and Drug Administration canceled an upcoming vaccine advisory committee meeting to discuss influenza virus strains, according to committee member Paul Offit. The meeting was scheduled for March 13. Committee members received a cancellation email — which was first reported by Jeremy Faust of Inside Medicine — on Wednesday afternoon.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Q&A: Pharmacists Can Help Fill Reproductive Health Care Gap
Drug Topics
FEBRUARY 26, 2025
Natalie DiPietro Mager, PharmD, PhD, discusses the role that community pharmacists can play in improving access to contraceptive services.
Could novel 3D printing method enhance intestinal drug delivery?
European Pharmaceutical Review
FEBRUARY 26, 2025
A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Antimicrobial Stewardship Critical For Mitigating Antibiotic Shortages
Drug Topics
FEBRUARY 26, 2025
In a systematic review of antibiotic drug shortages, researchers explored what causes them, how they impact health systems, and what officials commonly do to mitigate them.
Maximizing Impact Through Specialty Medication Therapy Management
PharmD Live
FEBRUARY 26, 2025
As specialty medications revolutionize treatment for chronic and complex conditions, their rising costs and intricate management requirements place a significant strain on patients, payers and providers. Without structured oversight, adherence issues, adverse drug interactions and financial barriers can lead to poor outcomes and unnecessary healthcare costs.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 26, 2025
National telehealth giant Teladoc reported a massive loss in 2024, dragged down by the declining value of its BetterHelp direct-to-consumer mental health business. | Teladoc released its full-year 2024 earnings on Wednesday.
Enhancing medical education through gamification and innovative technologies
pharmaphorum
FEBRUARY 26, 2025
Explore how gamification and innovative technologies can revolutionise medical education, making learning more engaging and effective. Discover the benefits and best practices for integrating gamification into medical training.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 26, 2025
The federal government must complete plans to fire even more workers and close down offices. HHS has special instructions to ensure health program care delivery is not disrupted.
FDA Approves Miudella, First Hormone-Free, Copper IUD in Over 40 Years
Pharmacy Times
FEBRUARY 26, 2025
The newly-approved intrauterine device (IUD) prevents pregnancy in people of reproductive potential for up to 3 years.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 26, 2025
An estimated $25.7 billion was spent by hospitals and health systems on claims adjudication in 2023, a 23% increase over 2022, according to a Premier member survey. Among the 15% of claims denied by insurers, more than two-thirds were ultimately paid out.
Women in science: Where are we now?
pharmaphorum
FEBRUARY 26, 2025
Explore the current state and achievements of women in science with insights from Michelle Bridenbaker, Alexandra Tabbitt, Agnes Cwienczek, Jean Redmond, Dr Jessica Steier, and Sabine Glden. Learn about their contributions and the progress being made in the field.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 26, 2025
Just over 34.4 million people were enrolled in Medicare Advantage plans as of Feb. 1, representing fairly slim growth across the program's annual enrollment period.
Bayer reveals phase 3 data for improved MRI contrast agent
pharmaphorum
FEBRUARY 26, 2025
Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
New Pricing, Access to Tirzepatide Available Through Self-Pay Options
Pharmacy Times
FEBRUARY 26, 2025
New options for tirzepatide provide a transparent, out-of-pocket choice for patients by streamlining the supply chain and bypassing insurance.
Can Keytruda finally break into early head and neck cancer?
pharmaphorum
FEBRUARY 26, 2025
The FDA is set to decide on MSD's Keytruda as perioperative treatment of locally advanced head and neck squamous cell carcinoma in June
Earlier Use of Long-Acting Injectable Treatments for Schizophrenia Has Multiple Benefits
Pharmacy Times
FEBRUARY 26, 2025
Research has demonstrated a reduction in hospitalization risk associated with the use of LAIs, but some barriers can prevent the wider adoption of this approach.
Eikon raises almost $351m to advance cancer candidates through the clinic
Pharmaceutical Technology
FEBRUARY 26, 2025
Eikons lead candidate EIK1001 is being investigated for melanoma in combination with MSDs Keytruda in a Phase III trial.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert: Inadequate Treatment Response, High Costs Common Challenges With IVIG Therapy in CIDP
Pharmacy Times
FEBRUARY 26, 2025
Intravenous immunoglobulin therapy for patients with CIDP requires navigating insurance coverage and prolonged therapy.
Fierce Healthcare - Untitled Article
Fierce Healthcare
FEBRUARY 26, 2025
Senior Editor Heather Landi, Senior Writer Paige Minemyer and Staff Writer Emma Beavins reflect on their trip to the ViVE conference in Nashville and what they learned.
Pembrolizumab Plus Standard of Care Receives Priority Review for Resectable Locally Advanced Head and Neck Cancer
Pharmacy Times
FEBRUARY 26, 2025
Pembrolizumab is a humanized monoclonal antibody that targets PD-1.
Perlmutter's Eikon raises $351m in major financing round
pharmaphorum
FEBRUARY 26, 2025
Eikon has added to its already copious cash reserves with a $351m round for its expanding pipeline of cancer therapies.
Pharmacists Optimize Management of Non-Tuberculous Mycobacterial Infections
Pharmacy Times
FEBRUARY 26, 2025
Clinical pharmacists can optimize treatment through effective medication management and therapeutic drug monitoring.
Data cues up AZ oral SERD filing in first-line breast cancer
pharmaphorum
FEBRUARY 26, 2025
AstraZeneca could be the first to bring an oral SERD to market in first-line breast cancer after camizestrant hit the mark in a phase 3 trial.
Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management
Pharmacy Times
FEBRUARY 26, 2025
Pharmacists play a crucial role in medication management for these complex patients.
Why non-diabetics using CGM may not be a good idea
pharmaphorum
FEBRUARY 26, 2025
A clinical trial has found that a continuous glucose monitor device systemically overestimated blood glucose levels when used by non-diabetic people.
Tenofovir Amibufenamide Comparable to TDF in the Treatment of Chronic Hepatitis B
Pharmacy Times
FEBRUARY 26, 2025
Although tenofovir amibufenamide and tenofovir disoproxil fumarate (TDF) had similar effects, the former resulted in better renal safety and did not impact lipid levels.
Emalex eyes FDA approval for Tourette syndrome therapy after Phase III success
Pharmaceutical Technology
FEBRUARY 26, 2025
The Phase III trial met the primary and secondary endpoints of reducing tics in children and adult patients with Tourette syndrome.
Mitazalimab shows promising survival rates in cancer study
Pharma Times
FEBRUARY 26, 2025
Updated data from phase 2 study reveals survival benefit
Idorsia’s Tryvio deal collapses, forcing company to find cash urgently
Pharmaceutical Technology
FEBRUARY 26, 2025
With a potential buyer not working out, Idorsia has adjusted an existing partnership and restructured bonds to raise cash.
FDA Accepts Supplemental New Drug Application for Teva, Medincell’s Uzedy for Bipolar I Disorder
PharmExec
FEBRUARY 26, 2025
The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients with bipolar I disorder.
RedHill and Hyloris sign agreement for Bekinda’s development
Pharmaceutical Technology
FEBRUARY 26, 2025
RedHill has signed an exclusive licensing agreement with Hyloris for the global development and commercialisation of RHB-102 (Bekinda).
Embracing My New Normal: A Story of Resilience and Purpose
NF2 BioSolutions
FEBRUARY 26, 2025
[IMAGE DESCRIPTION] A photo of Khristel Mae. My name is Khristel Mae Oliveros, 27 years old, from the Philippines. Five years ago, my life took an unexpected turn. I was diagnosed with multiple brain schwannomas, leading to the total loss of my hearing. I underwent four brain and brainstem surgeries, followed by radiotherapy. The journey was painful, uncertain, and at times overwhelming.
Let's personalize your content